Found: 168
Select item for more details and to access through your institution.
Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 16, p. 2964, doi. 10.1111/bph.16391
- By:
- Publication type:
- Article
Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
- By:
- Publication type:
- Article
Characteristics of Orthodontic Treatment in Cancer Survivors: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 2858, doi. 10.3390/jcm13102858
- By:
- Publication type:
- Article
Small RNA‐seq and clinical evaluation of tRNA‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRF<sup>HisGTG</sup> results in patients' poor treatment outcome.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1790, doi. 10.1111/bjh.19332
- By:
- Publication type:
- Article
Thrombotic and bleeding complications in patients with AL amyloidosis.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1816, doi. 10.1111/bjh.19331
- By:
- Publication type:
- Article
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 396, doi. 10.1002/ajh.27206
- By:
- Publication type:
- Article
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin‐associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 502, doi. 10.1002/ajh.27219
- By:
- Publication type:
- Article
Retinopathy in a Patient With IgM MGUS: Causal Association Or an Epiphenomenon?
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00988-x
- By:
- Publication type:
- Article
Long-term Survival in a Patient With Transformation of Waldenström's Macroglobulinemia into DLBCL.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 1, p. 77, doi. 10.21873/cdp.10289
- By:
- Publication type:
- Article
Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights.
- Published in:
- Journal of Cardiovascular Development & Disease (JCDD), 2023, v. 10, n. 12, p. 484, doi. 10.3390/jcdd10120484
- By:
- Publication type:
- Article
Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 7178, doi. 10.3390/jcm12227178
- By:
- Publication type:
- Article
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 411, doi. 10.1111/bjh.19042
- By:
- Publication type:
- Article
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 844, doi. 10.1016/j.clml.2023.07.013
- By:
- Publication type:
- Article
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4667, doi. 10.3390/cancers15184667
- By:
- Publication type:
- Article
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 13966, doi. 10.3390/ijms241813966
- By:
- Publication type:
- Article
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E226, doi. 10.1002/ajh.27001
- By:
- Publication type:
- Article
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
- Published in:
- Diseases, 2023, v. 11, n. 3, p. 123, doi. 10.3390/diseases11030123
- By:
- Publication type:
- Article
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 271, doi. 10.1111/ejh.13993
- By:
- Publication type:
- Article
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11829, doi. 10.3390/ijms241411829
- By:
- Publication type:
- Article
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 750, doi. 10.1002/ajh.26895
- By:
- Publication type:
- Article
Cardiac mechanics in response to proteasome inhibition: a prospective study.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 5, p. 643, doi. 10.1093/ehjci/jeac168
- By:
- Publication type:
- Article
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2266, doi. 10.3390/cancers15082266
- By:
- Publication type:
- Article
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04034-5
- By:
- Publication type:
- Article
Optimizing Adjuvant Therapy after Surgery for Colorectal Cancer Liver Metastases: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2401, doi. 10.3390/jcm12062401
- By:
- Publication type:
- Article
Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E65, doi. 10.1002/ajh.26823
- By:
- Publication type:
- Article
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 704, doi. 10.3390/v15030704
- By:
- Publication type:
- Article
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 765, doi. 10.3390/v15030765
- By:
- Publication type:
- Article
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5816, doi. 10.3390/cancers14235816
- By:
- Publication type:
- Article
Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7176, doi. 10.3390/jcm11237176
- By:
- Publication type:
- Article
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity.
- Published in:
- Molecules, 2022, v. 27, n. 22, p. 7929, doi. 10.3390/molecules27227929
- By:
- Publication type:
- Article
SARS‐CoV‐2 humoral responses following booster BNT162b2 vaccination in patients with B‐cell malignancies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 10, p. 1300, doi. 10.1002/ajh.26669
- By:
- Publication type:
- Article
Cardiopulmonary Exercise Physiology in AL Amyloidosis Patients with Cardiac Involvement and Its Association with Cardiac Imaging Parameters.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/jcm11185437
- By:
- Publication type:
- Article
Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1142, doi. 10.1002/ajh.26639
- By:
- Publication type:
- Article
Diabetes mellitus and multiple myeloma; common features of two distinct entities.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2022, v. 38, n. 5, p. 1, doi. 10.1002/dmrr.3535
- By:
- Publication type:
- Article
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3355, doi. 10.3390/jcm11123355
- By:
- Publication type:
- Article
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2768, doi. 10.3390/cancers14112768
- By:
- Publication type:
- Article
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3088, doi. 10.3390/jcm11113088
- By:
- Publication type:
- Article
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 2, p. 319, doi. 10.1007/s10238-021-00746-4
- By:
- Publication type:
- Article
Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E83, doi. 10.1002/ajh.26434
- By:
- Publication type:
- Article
Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 204, doi. 10.3390/biomedicines10020204
- By:
- Publication type:
- Article
Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 338, doi. 10.3390/biomedicines10020338
- By:
- Publication type:
- Article
Association Of -308G/A, -238G/A TNF-α Polymorphisms with Multiple Myeloma Risk and Survival: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e96, doi. 10.1016/j.clml.2021.08.010
- By:
- Publication type:
- Article
Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 356, doi. 10.1111/bjh.17841
- By:
- Publication type:
- Article
Olive oil intake and cancer risk: A systematic review and meta-analysis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261649
- By:
- Publication type:
- Article
Late‐onset hematological complications post COVID‐19: An emerging medical problem for the hematologist.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 119, doi. 10.1002/ajh.26384
- By:
- Publication type:
- Article
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. E27, doi. 10.1002/ajh.26406
- By:
- Publication type:
- Article
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221090089
- By:
- Publication type:
- Article
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1811, doi. 10.3390/biomedicines9121811
- By:
- Publication type:
- Article